使用级联注意力引导视觉Transformer对早期阿尔茨海默病[¹⁸F]Florbetapir PET淀粉样蛋白负荷进行分层
本研究基于两个队列共1327例接受[¹⁸F]Florbetapir PET的受试者,开发级联注意力引导视觉Transformer(CA-ViT)模型,将β-淀粉样蛋白沉积分为阴性、不确定和阳性三类。模型在两个队列的三分类任务中准确率分别为82.8%[79.1%,86.5%](96%CI)和78.0%[75.1%,80.9%],医师在模型辅助下诊断准确率从56%提升至66%、从50%提升至77%。
要点
- CA-ViT模型可对[¹⁸F]Florbetapir PET的β-淀粉样蛋白沉积进行阴性、不确定、阳性三分类。
- 模型在两个队列的三分类准确率分别为82.8%[79.1%,86.5%](96%CI)和78.0%[75.1%,80.9%]。
- 医师在模型辅助下诊断准确率从56%升至66%、从50%升至77%。
核心结论
- CA-ViT模型能有效解码[¹⁸F]Florbetapir PET影像中的细粒度病理信息,实现β-淀粉样蛋白沉积的准确分层,辅助医师对早期阿尔茨海默病进行监测。
研究设计与样本
- 研究纳入两个队列共1327例接受[¹⁸F]Florbetapir PET的受试者,按β-淀粉样蛋白沉积分组;提出级联注意力引导视觉Transformer(CA-ViT)框架提取具有生物学意义的区域信息进行细粒度分类;并评估医师在有无该方法辅助下的诊断性能。
诊断标准与关键数值
- CA-ViT模型在两个队列的三分类任务中准确率分别为82.8%[79.1%,86.5%](96%CI)和78.0%[75.1%,80.9%]。
- 医师无模型辅助时诊断准确率分别为56%和50%,有模型辅助时分别为66%和77%。
临床应用与阅片要点
- 作者指出,不确定的淀粉样蛋白沉积常使早期阿尔茨海默病诊断复杂化,并可能延迟最佳干预。
- 作者认为该模型在多中心PET扫描上验证,增强了对不确定病例的识别,并提高了经验较少医师的诊断准确率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aims to develop a deep learning model to assist physicians in accurately classifying negative, equivocal, and positive β-amyloid (Aβ) deposition stages in Alzheimer's disease (AD).
MATERIALS AND METHODS: 1327 subjects from two cohorts underwent [¹⁸F]Florbetapir PET and were grouped by Aβ deposition. A cascaded attention-guided vision transformer (CA-ViT) framework was proposed to extract biologically significant regional information for fine-grained classification. To evaluate clinical utility, we assessed the diagnostic performance of physicians with and without the assistance of our proposed method.
RESULTS: The CA-ViT model demonstrated outstanding cross-center performance, achieving accuracies of 82.8% [79.1%, 86.5%] (96% confidence interval, CI) and 78.0% [75.1%, 80.9%] in three-class classification tasks in the two cohorts, respectively. Our proposed model-assisted physicians exhibited significant improvements in diagnostic accuracy (from 56% to 66% and from 50% to 77%).
CONCLUSION: The CA-ViT model effectively decodes fine-grained pathological information from [¹⁸F]Florbetapir PET imaging, enabling accurate stratification of Aβ deposition to assist physicians in early monitoring of AD.
KEY POINTS: Question Deep learning has the potential to assist physicians in accurately classifying β-amyloid deposition stages in early Alzheimer's disease. Findings The proposed diagnostic model is a promising computer-aided tool for early assessment of amyloid deposition and demonstrates improved physician performance. Clinical relevance Equivocal amyloid deposition often complicates early Alzheimer's disease diagnosis and may delay optimal interventions. Our model, validated on PET scans from multiple centers, enhances the identification of these equivocal cases and improves diagnostic accuracy among less-experienced physicians.
引用
- Wang C, Zhang H, Jiao F, et al. Stratifying amyloid burden in early Alzheimer's disease using cascaded attention-guided vision transformer using [¹⁸F]Florbetapir PET. Eur Radiol. 2026. PMID: 41537783. doi:10.1007/s00330-025-12261-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。